What Founders Get Wrong About SAFEs

June 4, 2026

668 words | 2.5-minute read

You’ve signed your first customer, and you’re getting traction. Someone with money says, “I’d love to invest,” and mentions a SAFE.

If you’ve never raised capital before, that moment is equal parts exciting and disorienting. SAFEs dominate early-stage fundraising, and for good reason. But “simple” doesn’t mean “consequence-free.” Founders who don’t understand how SAFEs work often sign several without modeling the impact, then stare at a capitalization table they don’t recognize when the first real funding round arrives.

Before you sign anything, here’s what you need to know.

Why it matters: A SAFE is likely the first legal commitment you’ll make to an investor. Getting it wrong doesn’t hurt today; it hurts when it’s hardest to absorb — right before, or right after, your Series A.

1. What a SAFE actually is.

SAFE stands for Simple Agreement for Future Equity. The investor gives the company money now; in exchange, they receive the right to convert that investment into equity later — typically when the company raises a priced equity round. Y Combinator created the instrument in 2013, and it has since become the dominant early-stage fundraising tool. It’s a six-page standardized document, freely available on YC’s website.

Founders love SAFEs for obvious reasons. They close fast, require minimal legal fees, and, critically, carry no debt. Unlike a convertible note, if the SAFE never triggers, you don’t owe the money back and no interest accrues. It’s a clean instrument when used correctly.

2. How conversion works.

A SAFE converts into preferred equity when the company raises a priced equity round — a round where investors and the company agree on a pre-money valuation. SAFEs don’t convert on other SAFEs or convertible notes. When conversion occurs, SAFE holders receive the same series of preferred stock as incoming investors, typically at a lower price per share due to a discount, valuation cap, or both.

How many shares they receive depends on the SAFE’s economics. Two mechanisms control this:

When a SAFE includes both, the investor gets whichever produces the better deal for them. As a founder, the ideal outcome, if you have the negotiating leverage, is a discount with no cap. That avoids locking in a premature valuation before your company has found its footing.

3. Where founders go wrong.

One of the problems with SAFEs isn’t the instrument; it’s accumulation. Because they’re quick and easy to sign, founders close multiple rounds of SAFEs at different caps and discounts without ever modeling the cumulative effect on their ownership. Then a Series A term sheet arrives, the SAFEs convert simultaneously, and the dilution is far larger than anyone anticipated.

Before you sign your second SAFE, run the numbers with your attorney. Model what conversion looks like under different scenarios. This is exactly what legal counsel is for, and skipping that step is one of the most common and most expensive mistakes early-stage founders make.

4. Two clauses that deserve attention.

Most Favored Nation (MFN): This lets an early SAFE investor upgrade their terms if you later give better terms to someone else. It sounds harmless. In practice, it can trigger a cascade of dilution you didn’t plan for. Push back if you have the leverage to.

Pro-rata rights (via side letter): Gives investors the right to participate in future rounds to maintain their ownership percentage. That’s a reasonable ask from a serious investor. What raises a flag is a side letter that bundles an extensive list of additional rights alongside the pro-rata. Read it carefully and have your attorney review it before you sign.

The bottom line: SAFEs are fast, founder-friendly, and widely used for good reason — but signing several without understanding the math is how founders give away their company before it’s worth anything.

Ruta.Legal Newsletter

Where founders learn about basic legal stuff they need to start, run, and grow their business. By a 15-year attorney and operator.

Subscribe